Recurrences and related characteristics of gastric cancer

British Journal of Cancer

Volumn 74, Issue 6, 1996, Pages 975-979

  Maehara, Y ^a   Emi, Y ^a   Baba, H ^a   Adachi, Y ^a   Akazawa, K ^a   Ichiyoshi, Y ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Depth of invasion; Gastric cancer; Proliferating cell nuclear antigen

Indexed keywords

CYCLINE;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR VOLUME;

EID: 0029736905     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.468     Document Type: Article

References (34)

1. ADACHI Y, KAMAKURA T, MORI M, BABA H, MAKHARA Y AND SUGIMACHI K. (1994). Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br. J. Surg., 81, 414 -416.
2. BABA H, KORENAGA D, OKAMURA T, SAITO A AND SUGIMACHI K. (1989). Prognostic factors in gastric cancer with serosal invasion. Arch. Surg., 124, 1061-1064.
3. BABA H, MAEHARA Y, TAKEUCHI H, INUTSUKA S, OKUYAMA T, ADACHI Y, AKAZAWA K AND SUGIMACHI K. (1995). Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery, 117, 165-169.
4. BOZZETTI F, BONFANTI G, BUFALINO R, MENOTTI V, PERSANO S, ANDREOLA S, DOCI R AND GENNARI L. (1982). Adequacy of margins of resection in gastrectomy for cancer. Ann. Surg., 196, 685-690.
5. COX DR. (1972). Regression models and life tables. J. R Stat. Soc. (B), 34, 187-220.
6. DIXON WJ (ed.). (1988). BMDP Statistical Software, pp. 229-718. University of California Press. Berkeley.
7. HALL PA, LEVISON DA, WOODS AL, YU CC-W, KELLOCK DB, WATKINS JA, BARNES DM, GILLETT CE, CAMPLFJOHN R, DOVER R, WASEEM NH AND LANE DP. (1990). Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol., 162, 285-294.
8. HERMANEK P AND SOBIN LH (ed.). (1987). TNM Classification of Malignant Tumours. Fourth, fully revised version, pp.43-46. Springer-Verlag: Berlin.
9. HIRONO Y, TSUGAWA K, FUSHIDA S, NINOMIYA I, YONEMURA Y, MIYAZAKI I, ENDOU Y, TANAKA M AND SASAKI T. (1995). Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer. Oncology, 52, 182-188.
10. ICHIYOSHI Y, TODA T, MINAMISONO Y, NAGASAKI S, YAKEISHI Y AND SUGIMACHI K, (1990). Recurrence in early gastric cancer. Surgery, 107, 489-495.
11. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1981). The General Rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Clinical Classification. Jpn. J. Surg., 11, 127 -139. Part II. Histological classification of gastric cancer. Jpn. J. Surg., 11, 140-145.
12. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1981). The General Rules for the Gastric Cancer Study in Surgery and Pathology. Part I. Clinical Classification. Jpn. J. Surg., 11, 127 -139. Part II. Histological classification of gastric cancer. Jpn. J. Surg., 11, 140-145.
13. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. (1993). The General Rules for Gastric Cancer Study. 12th edn. (in Japanese). Kanehara: Tokyo.
14. JOYPAUL BV, HOPWOOD D, NEWMAN EL, QURESHI S, GRANT A, OGSTON SA, LANE DP AND CUSCHIERI A. (1994). The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br. J. Cancer, 69, 943-946.
15. KAKEJI Y, MAEHARA Y, ADACHI Y, BABA H, MORI M, FURUSAWA M AND SUGIMACHI K. (1994). Proliferating activity as a prognostic factor in Borrmann type 4 gastric carcinoma. Br. J. Cancer, 69, 749-753.
16. KAWASAKI S. (1975). A clinicopathological study on upward intramural extension of cancer of the stomach, (in Japanese with English abstract). Fukuoka Acta Medica, 66, 1-23.
17. KORENAGA D, OKAMURA T, BABA H, SAITO A. AND SUGIMACHI K. (1988a). Results of resection of gastric cancer extending to adjacent organs. Br. J. Surg., 75, 12-15.
18. KORENAGA D, OKAMURA T, SAITO A, BABA H AND SUGIMACHI K. (1988b). DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer. Cancer, 62, 309-313.
19. LEE EY, CIBULL ML, STRODEL WE AND HALEY JV. (1994). Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. Arch. Pathol. Lab. Med., 118, 235-239.
20. MAEDA K, CHUNG YS, ONODA N, KATO Y, NITTA A, ARIMOTO Y, YAMADA N, KONDO Y AND SOWA M. (1994). Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer, 73, 528-533.
21. MAEHARA Y, SUGIMACHI K, AKAGI M, KAKEGAWA T, SHIMAZU H AND TOMITA M. (1990). Serum carcinoembryonic antigen level increases correlation with tumor progression in patients with differentiated gastric carcinoma following noncurative resection. Cancer Res., 50, 3952-3955.
22. MAEHARA Y, MORIGUCHI S, YOSHIDA M, TAKAHASHI I, KORENAGA D AND SUGIMACHI K. (1991a). Splenectomy does not correlate with length of survival in patients undergoing curative total gastrectomy for gastric carcinoma. Cancer, 67, 3006-3009.
23. MAEHARA Y, MORIGUCHI S, KAKEJI Y, KOHNOE S, KORENAGA D, HARAGUCHI M AND SUGIMACHI K. (1991b). Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery, 110, 820-823.
24. MAEHARA Y, OKUYAMA T, MORIGUCHI S, ORITA H, KUSUMOTO H, KORENAGA D AND SUGIMACHI K. (1992). Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer, 70, 392-395.
25. MAEHARA Y, OKUYAMA T, OSHIRO T, BABA H, ANAI H, AKAZAWA K AND SUGIMACHI K. (1993). Early carcinoma of the stomach. Surg. Gynecol. Obstet., 177, 593-597.
26. MAEHARA Y, OKUYAMA T, KAKEJI Y, BABA H, FURUSAWA M AND SUGIMACHI K. (1994). Postoperative immunochemotherapy including Streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion. Am. J. Surg., 168, 36-40.
27. MAEHARA Y, OSHIRO T, OIWA H, ODA S, BABA H, AKAZAWA K AND SUGIMACHI K. (1995a). Gastric cancer in patients over 70 years of age. Br. J. Surg., 82, 102-105.
28. MAEHARA Y, OSHIRO T, BABA H, OHNO S, KOHNOE S AND SUGIMACHI K. (1995b). Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery, 117, 380-385.
29. MOREAUX JAND BOUGARAN J. (1993). Early gastric cancer. A 25-year surgical experience. Ann. Surg., 217, 347-355.
30. MORIGUCHI S, MAEHARA Y, KORENAGA D, SUGIMACHI K AND NOSE Y. (1992a). Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg. Oncol., 1, 341-346.
31. MORIGUCHI S, MAEHARA Y, KORENAGA D, KAKEJI Y, SUGIMACHI K AND NOSE Y. (1992b). The relationship between prognostic significance of pathological type and the degree of gastric wall invasion in gastric cancer. Cancer J., 5, 220-223.
32. NOGUCHI Y. (1990). Blood vessel invasion in gastric carcinoma. Surgery, 107, 140-148.
33. ORITA H, MATSUSAKA T, WAKASUGI K, KUME K, FUJINAGA Y, FUCHIGAMI T AND IWASHITA A. (1992). Clinicopathologic evaluation of recurrence in early gastric cancer. Surgery Today, 22, 19-23.
34. WASEEM NH AND LANE DP. (1990). Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J. Cell Sci., 96, 121-129.